ESC 365 - Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

ESC Premium Access

Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Session: Poster Session 1 - Chronic heart failure – Treatment

Topic: Pharmacotherapy

Speaker: Professor U. Zeymer (Ludwigshafen, DE)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)

18 presentations

3 followers

7 more presentations in this session

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Speaker: Doctor T. Noto (Sapporo, JP)

Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus.

Speaker: Professor C. Lang (Dundee, GB)

Diminished response to statin therapy predicts future occurrence of heart failure in patients with acute myocardial infarction

Speaker: Doctor K. Tsuda (Takatsuki, JP)

Titration patterns and clinical characteristics of patients prescribed sacubitril/valsartan in the primary care and cardiology settings in germany

Speaker: Associate Professor R. Wachter (Leipzig, DE)

Heart rate reduction by selective sinus node blocker (ivabradine) protects against detrimental hemodynamic and structural effects of iv inotrops in heart failure

Speaker: Professor P. Leszek (Warsaw, PL)

Access the full session

Poster Session 1 - Chronic heart failure – Treatment

Speakers: Professor U. Zeymer, Doctor T. Noto, Professor C. Lang, Doctor K. Tsuda, Associate Professor R. Wachter...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources